The global anti-asthmatic drugs market is anticipated to grow at a significant CAGR of 8.2% during the forecast period. Asthma is a condition that causes the respiratory tract to become thin and swollen and produce more mucus. It can make breathing difficult, causing coughing, shortness of breath, and shortness of breath in asthma patients. According to the WHO, asthma is most common non-communicable disease in children and 15.0-18.0% cases are found in developed countries, every year. Asthma is most of the common chronic diseases in children. Furthermore, as per the study conducted by National Health and Planning Commission in 2019, 30 million people in China suffered from asthma and only 28% of the people with asthma have their condition under control. The growth is fueled by the increasing prevalence of asthma, rising the demand for long-term control medication and rescue medication across the globe. For instance, in September 2019, Novartis announced the positive results from the phase III IRIDIUM study of inhaled combination QVM149 in patients diagnosed with uncontrolled asthma.
To Request a Sample of our Report on Global Anti-Asthmatic Drugs Market: https://www.omrglobal.com/request-sample/anti-asthmatic-drugs-market
The global is global anti-asthmatic drugs was hit by the outbreak of COVID-19 in December 2019. The drug and device shortage during the COVID pandemic has gained pharma companies’ interest in delivering quickly. The outbreak of COVID-19 has disrupted the supply of raw materials and products across the globe, hence impacted the congenital heart disease market negatively. For instance, according to the National Institute of Health of the US, medication shortages in 2020 have been shown at 87 % as compared to 2019. Further, COVID-19 affected people who have moderate-to-severe asthma or uncontrolled asthma. According to World Health Organization (WHO), most people with asthma, particularly those with non-allergic asthma, are at a slightly higher risk of serious disease from COVID-19 than the general population.
A full Report of Global Anti-Asthmatic Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-asthmatic-drugs-market
Global Anti-Asthmatic Drugs Market Segmentation
By Type
- Long-term Control Medications
- Quick-relief Medications
- Medications for Allergy-induced Asthma
By Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Abbott Laboratories, Inc
- Almirall, S.A
- Astellas Pharma Inc.,
- Boehringer Ingelheim GmbH
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- GE Healthcare
- Merck & Co.
- Pfizer Inc.
- Mitsubishi Tanabe Pharma Corp.
- Regeneron Pharmaceuticals Inc.
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceuticals Industries
- Theravance Biopharma Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-asthmatic-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
